Therefore, ZNF306 may serve as a marker for the development of distal metastasis in CRC, while anti‐angiogenic drugs or HFI1A antagonists can be used for CRCs caused by ZNF306 deficiency, thereby inhibiting distal metastasis in CRC. The gene discussed is ZKSCAN3; the disease is colorectal carcinoma.